Structural requirements for nicotine and cyclic imine-induced amine release from neoplastic mast cells.
D000588:Amines / Q000378:metabolism*; D000818:Animals; D001385:Azetines / Q000494:pharmacology; D001389:Azirines / Q000494:pharmacology; D002460:Cell Line; D055598:Chemical Phenomena; D002621:Chemistry; D004583:Electrons; D006863:Hydrogen-Ion Concentration; D007093:Imidazoles / Q000494:pharmacology; D007097:Imines / Q000494:pharmacology*; D007700:Kinetics; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D009369:Neoplasms / Q000378:metabolism*; D009538:Nicotine / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology; D011758:Pyrroles / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D012995:Solubility; D013050:Spectrometry, Fluorescence; D013329:Structure-Activity Relationship
D000588:Amines; D001385:Azetines; D001389:Azirines; D007093:Imidazoles; D007097:Imines; D010880:Piperidines; D011758:Pyrroles; D011759:Pyrrolidines; D012701:Serotonin; D009538:Nicotine